Member Info for 13martyn13

Could WPHO be on someone’s takeover list?
PreSeed Ventures A/S had a holding of 7.5% now sold down to 0%, transaction was today.
Last Friday SEED Capital Denmark 11 K/S sold their 12% down to 0%.
So 20% sold in a week…but to whom?

Two trades, 3 minutes after my post :-)
Moved the price up again though.

Hi RichWG & Johnnyy.
Seems we have the same positive expectations, but I also take heart from days like these when there’s no displayed trades but the market makers move their prices up, always a good sign.

520,636 shares @ 111p, continued show of confidence.

Not the best news that our biggest shareholder has gone from nearly 12% down to 0%.
But then someone must’ve bought them.

Well OBD really need the share price to rise to encourage shareholders to take up the open offer.
But the bulk of the raise £9.1M should be in the bag, subject to a vote, which usually gets passed.
If we take up the offer, it helps the company because OBD will get our cash.
If we buy in the market instead, it doesn’t help OBD, because the placing shares might not get taken up, unless our buying in the market pushes up the share price above the 20p, encouraging other shareholders to take up the offer shares.
I think the closing date is about 20th October, but don’t hold me to that, so we have a little time to make up our minds, or just buy in the market now if you believe OBD have a good future.

OBD are issuing new shares to shareholders on the terms of 1 New Share for every 6.81644 share.
So divide your holding by 6.81644 to give you your entitlement and then multiply that by the 20p issue price and that’s how much it will cost you to participate.
If you don’t take up the new shares then you’ll end up holding the same amount but your % of the company will be less.
Issuing new shares at a premium is a good show of strength and they have conditionally raised £9.1M with Institutional Investors.

Results due this month and should show the increased turnover as promised,
“A significant increase in contracted annual recurring revenues ("ARR"), a key metric for the business, is expected to be delivered, with ARR for the full year of c. £15m (2021: £1.8m). Following upgraded market expectations adjusted EBITDA was at a breakeven level (2021 EBITDA loss: £4.1m) and net cash at 31 March 2022 was £7.5m (2021: £2.4m)”.
So these results are already six months old.
Pinning my hopes on an outstanding update on trading, which could move the price up quite quickly, with any luck :-)

Interesting to to see a 100,000 share deal at 16:26:16 today in USD priced at 16.773c.

A welcome bit of interest today, on the back of Mondays RNS about our reimbursement code becoming live maybe.

“£300K profit from K-pop”?
I read the …
The event took place on 14 and 15 May 2022 to great acclaim with KPE reporting a profit from the event of £160,000 (£80,000 net share due to LVCG) which, for a first event was positive. In addition to the profit share, LVCG was also able to recover £137,000 of staff costs which was below our expectations although we hope to recover some of the shortfall from future events.

After a very quick read, the figure that stood out to me was the £80,000 profit from Frankfurt, not as much as I was hoping for.

My holding in SIPP with ii. Divi always gets paid in $.
15,000 shares is $637.50, just converted to £582.64 giving me an extra £33.64, 3.88p compared to the 3.66p Stirling payment.
SIPP holding purchased at 73p, I’m pleased with the share buyback.
ISA holding, which I’ve sold, always got paid in Stirling by default.

Another nice dividend increase announced today, no RNS showing here though.

“The interim dividend of 2.9425p per Ordinary share will be paid on 14 October 2022 to the holders of Ordinary shares on the register at 23 September 2022, with an ex-dividend date of 22 September 2022.

It is the Board's intention that this payment will be the first of four equal core dividend payments of 2.9425p each, being a total of 11.77p, for the year ending 30 April 2023”

Bit more interest this morning, which hopefully bodes well for the full year results expected within the next three trading days.

Is almost back to where it was before the June drop on the results & Financing RNS.
Now all we need is large growing sales and a very confident forward looking statement in tomorrow’s interim results.

The energy hedging has to help.
“We pro-actively sought to mitigate both the present and future utilities cost inflation risk by contracting long term price hedges on both the Group's gas and electric supplies in Q3 of 2020. Using the 2019 financial year volumes as the basis for this decision, the Group has hedged”

· 100% of its gas until December 2023;
· 100% of its electricity until March 2022; and then
· 50% of its electricity until March 2023; and then
· 25% of its electricity until December 2023.

I will say, WSBN never have a problem raises cash.
“A private placement”, hopefully long term holders, we’ll see.

The beauty of STX is that they have a great product approved and being sold, that just needs ramping up.
As others have thought, there’s plenty of valve in these unloved small pharma companies.
Unfortunately I need 23.5p to break even, which is easily achievable with the right news.

DNL is a small struggling pharma company that is being taken over for a 144% premium.